Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioharvest Sciences Inc (OP: CNVCF )

5.610 +0.010 (+0.18%)
Streaming Delayed Price Updated: 3:39 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bioharvest Sciences Inc

< Previous 1 2 3 Next >
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest"... 
Via Newsfile
BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 23, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 16, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 20, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024
Via ACCESSWIRE
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 12, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest"... 
Via Newsfile
BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 4, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results
Q2 2024 Revenue Increased 119% Year-over-Year to Over $6.0 Million, Exceeding Management Guidance Management Expects Third Quarter 2024 Revenues of... 
Via Newsfile
BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 23, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences Reports First Quarter 2024 Financial Results
Q1 2024 Revenue Increased 147% Year-over-Year to US$5.34 Million Exceeding Previous Guidance Management Expects Q2 2024 Revenue in the Range... 
Via Newsfile
BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 1, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results
FY 2023 Revenue Increased 2.3x to $12.7 Million USDThe Company expects Q1 2024 Revenue to be in the range of... 
Via Newsfile
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity
80,000 Square Foot (7,500 Square Meter) Property includes 12 GMP Clean Rooms, Laboratory and Office space, and can accommodate expanded... 
Via Newsfile
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 21, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 14, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 13, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the... 
Via Newsfile
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 26, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 15, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 12, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
Life Science Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
BioHarvest Sciences to Present at the Life Sciences Investor Forum December 14th
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Life Science Investor Forum Agenda Announced for December 14th, 2023
From Virtual Investor Conferences
Via GlobeNewswire
BioHarvest Sciences Inc. Announces $11.78M Raised in First Tranche of $13.5M Private Placement
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 30, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
Health Canada Grants BioHarvest Sciences License for VINIA Sales in Canada
Significant milestone marking the beginning of VINIA® geographical expansion beyond Israel and the US Further validation from global health authorities... 
Via Newsfile
BioHarvest Announces August 2023 U.S. VINIA Sales Exceeded USD $1Million
Significant milestone demonstrating sales momentum of VINIA®Further validation of the Botanical Synthesis Technology PlatformStrong justification of the Direct-to-Consumer sales strategyVancouver,... 
Via Newsfile
BioHarvest Sciences Reports Q2 2023 Results Demonstrating Continued Growth Momentum
Q2 VINIA® revenues of USD 2.75M represent growth of 228% compared to Q2 2022 and 27% compared to Q1 2023... 
Via Newsfile
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.